Kindred Healthcare (KND) Cut to “D+” at TheStreet

TheStreet downgraded shares of Kindred Healthcare (NYSE:KND) from a c- rating to a d+ rating in a research report released on Tuesday.

A number of other equities analysts have also commented on the stock. Zacks Investment Research lowered shares of Kindred Healthcare from a buy rating to a hold rating in a research report on Wednesday, January 17th. ValuEngine lowered shares of Kindred Healthcare from a sell rating to a strong sell rating in a research report on Friday, May 4th. Three research analysts have rated the stock with a sell rating and five have given a hold rating to the company’s stock. The stock currently has a consensus rating of Hold and a consensus target price of $8.33.

Kindred Healthcare opened at $8.95 on Tuesday, MarketBeat Ratings reports. The company has a debt-to-equity ratio of 10.04, a current ratio of 1.73 and a quick ratio of 1.70. Kindred Healthcare has a 12 month low of $8.95 and a 12 month high of $9.00. The company has a market capitalization of $816.78 million, a PE ratio of 26.32 and a beta of 1.13.

Kindred Healthcare (NYSE:KND) last released its quarterly earnings data on Wednesday, February 28th. The health services provider reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of $0.18 by $0.02. Kindred Healthcare had a negative net margin of 11.56% and a positive return on equity of 11.38%. The company had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.48 billion. During the same period last year, the business earned $0.05 earnings per share. Kindred Healthcare’s revenue was down 2.2% compared to the same quarter last year. equities research analysts predict that Kindred Healthcare will post 0.64 EPS for the current year.

A number of institutional investors have recently made changes to their positions in KND. Water Island Capital LLC bought a new stake in Kindred Healthcare during the first quarter valued at approximately $28,103,000. UBS Group AG lifted its position in Kindred Healthcare by 46,724.7% during the first quarter. UBS Group AG now owns 2,564,122 shares of the health services provider’s stock valued at $23,461,000 after purchasing an additional 2,558,646 shares during the last quarter. SG Americas Securities LLC lifted its position in Kindred Healthcare by 301.3% during the first quarter. SG Americas Securities LLC now owns 854,702 shares of the health services provider’s stock valued at $7,821,000 after purchasing an additional 641,736 shares during the last quarter. Capital Fund Management S.A. bought a new stake in Kindred Healthcare during the fourth quarter valued at approximately $6,128,000. Finally, Citigroup Inc. lifted its position in Kindred Healthcare by 719.9% during the first quarter. Citigroup Inc. now owns 666,489 shares of the health services provider’s stock valued at $6,099,000 after purchasing an additional 585,196 shares during the last quarter. Institutional investors and hedge funds own 88.39% of the company’s stock.

Kindred Healthcare Company Profile

Kindred Healthcare, Inc provides healthcare services in the United States. It operates through five segments: Home Health Services, Hospice Services, Hospitals, Kindred Hospital Rehabilitation Services, and RehabCare. The company provides long-term acute care (LTAC) services to post-intensive care and medically complex patients, including the critically ill and suffering from multiple organ system failures most commonly of the cardiovascular, pulmonary, kidney, gastro-intestinal, and cutaneous systems.

Analyst Recommendations for Kindred Healthcare (NYSE:KND)

Receive News & Ratings for Kindred Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.



Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit